MARC Record from Library of Congress

LEADER: 04082cam a22003137a 4500
001 2008010058
003 DLC
005 20090701101126.0
008 080306s2008 miu b 001 0 eng
010 $a 2008010058
020 $a9780737739626 (hardcover)
020 $a0737739622 (hardcover)
020 $a9780737739633 (pbk.)
035 $a(OCoLC)192079717$z(OCoLC)192079718
035 $a(OCoLC)ocn192079717
040 $aDLC$cDLC$dYDX$dBTCTA$dYDXCP$dBAKER$dSVW$dJED$dQBX$dDLC
050 00 $aRM301.15$b.P735 2008
082 00 $a338.4/76151$222
245 00 $aPrescription drugs /$cSylvia Engdahl, book editor.
260 $aDetroit :$bGreenhaven Press/Gale Cengage Learning,$cc2008.
300 $a246 p. ;$c24 cm.
440 0 $aCurrent controversies
504 $aIncludes bibliographical references (p. 227-235) and index.
505 00 $tIs too little attention given to the safety of prescription drugs? Yes : Problems often show up after a prescription drug is on the market. Off-label prescription of drugs can lead to adverse effects /$rHazel Muir --$tSome prescription drugs on the market are unsafe /$rConsumer reports --$tPrescription drugs can cause serious harm when risks are ignored /$rSusan Kelleher --$tPost-marketing study of prescription drugs is not adequate /$rDavid J. Graham --$tNo : Too much caution deprives patients of prescription drugs they need. Excessive caution in drug approval causes more harm than it prevents /$rScott Gottlieb --$tPanic over prescription-drug risks leads people to stop taking needed medication /$rIrene S. Levine --$tSafety concerns about prescription drugs are exaggerated and will result in higher prices /$rHenry I. Miller --$tLengthy approval process for prescription drugs costs lives /$rGilbert L. Ross --$tTerminally ill patients should be allowed to use experimental drugs /$rSigrid Fry-Revere --$tDo pharmaceutical companies promote unnecessary drugs? Direct-to-consumer prescription drug advertising : an overview /$rCarol Rados --$tYes : Many new drugs are developed merely for commercial reasons. Pharmaceutical companies define normal conditions as diseases /$rRay Moynihan, Alan Cassels --$tDrug promotion plays on people's fears of future illness /$rBarbara Mintzes --$tDrug promotion has led to the overmedication of children /$rAnne Taylor Fleming --$tNo : New drugs help people who would otherwise lack effective treatment. Drugs for minor conditions are important to many people /$rGlenn Harlan Reynolds --$tImproved prescription drugs mean better medical treatment and less illness /$rAlan F. Holmer --$tDirect-to-consumer prescription drug advertising helps people get treatment for undiagnosed diseases /$rPaul Antony --
505 00 $tDo prescription drugs in America cost too much? Rising cost of prescription drugs : an overview --$tYes : American pharmaceutical companies charge too much. Many people cannot afford the prices set by the profit-driven drug industry /$rKatharine Greider --$tImporting less-costly prescription drugs from abroad should be allowed /$rNelda Barnett --$tNew cancer drugs cost more than their brief extending of life may be worth /$rDaniel Costello --$tNo : pharmaceutical companies need profits to do research. High prices of drugs for minor problems pay for drugs that cure more serious ones /$rPeter W. Huber --$tMedical innovation would stop if the government controlled drug prices /$rSidney Taurel --$tControlling drug prices would reduce access to medicine /$rDoug Bandow --$tAre dishonest or illegal prescription drug practices common? Gifts from pharmaceutical companies influence doctors /$rAdriane Fugh-Berman, Shahram Ahari --$tMedia reporting about prescription drugs is often inaccurate /$rRichard A. Deyo, Donald L. Patrick --$tPrescription drugs are often abused /$rNichole Aksamit --$tYoung people often trade prescription drugs with friends /$rAmy Harmon --$tTeens use prescription drugs to get high /$rDonna Leinwand.
650 0 $aDrugs$xPublic opinion.
650 0 $aPharmaceutical industry.
650 0 $aPharmaceutical policy.
700 1 $aEngdahl, Sylvia.